Superagers have faster movement speed than typical older adults
Jul 17, 2023
Superagers exhibit higher grey matter volume cross-sectionally in the medial temporal lobe, cholinergic forebrain and motor thalamus.
Variation in total cholesterol, triglycerides linked to Alzheimer’s disease risk
Jul 06, 2023
Those in the highest quintile of total cholesterol and triglycerides had increased risk for Alzheimer’s disease and Alzheimer’s-related dementias.
Number of teeth, periodontitis in older adults linked to hippocampal atrophy
Jul 06, 2023
A qualitative interaction was seen between the number of teeth present and the mean periodontal probing depth for symmetric percentage change in left hippocampus.
Intranasal insulin may have pro-cognitive benefits
Jun 30, 2023
Improvement in global cognition was seen for patients with Alzheimer’s disease/mild cognitive impairment, but no effects were seen for healthy individuals or other patient populations.
FDA advisers say next round of COVID-19 booster shots should target an XBB Variant
Jun 15, 2023
Protection against the original strain of the virus will be dropped from the updated vaccines as it could contribute to lower vaccine efficacy against newer strains.
Medicare will cover new class of Alzheimer’s drugs if fully approved by FDA, with limits
Jun 02, 2023
Drug makers also will have to gather and keep data in a registry showing how the drugs are working in the real world.
Sleep-disordered breathing linked to medial temporal lobe atrophy in seniors
Jun 02, 2023
Higher sleep apnea severity was related to lower medial temporal lobe subregion volumes in amyloid-positive, but not amyloid-negative, individuals.
FDA grants full approval to Paxlovid to treat COVID-19
May 25, 2023
Paxlovid has been taken by older adults and others at high risk for severe COVID-19 under an emergency use approval.
Allopurinol may cut risk for neurodegenerative diseases
May 19, 2023
Allopurinol linked to 13 to 34 percent lower risk for Parkinson disease, Alzheimer disease, ALS
Experimental drug for Alzheimer’s disease slows decline in thinking
May 03, 2023
Eli Lilly says the drug slows memory and thinking declines in early symptomatic Alzheimer’s disease patients by more than a third.